Cargando…

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer

Mostrar otras versiones (1)

The objective of the present study was to analyze the prognostic relevance of pretreatment serum CA125 ≥500 U/ml and its role as a non-invasive factor for estimating optimal cytoreduction (≤1 cm) in primary serous ovarian cancer. Clinicopathological parameters and CA125 levels prior to primary cytor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachmann, Robert, Brucker, Sara, Stäbler, Annette, Krämer, Bernhard, Ladurner, Ruth, Königsrainer, Alfred, Wallwiener, Diethelm, Bachmann, Cornelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690236/ https://www.ncbi.nlm.nih.gov/pubmed/33262888 http://dx.doi.org/10.3892/mco.2020.2170

Ejemplares similares

Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
por: Bachmann, Robert, et al.
Publicado: (2021)

Incidence and Impact of Lymph Node Metastases in Advanced Ovarian Cancer: Implications for Surgical Treatment
por: Bachmann, Cornelia, et al.
Publicado: (2016)

High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
por: Morales-Vásquez, Flavia, et al.
Publicado: (2016)

University Gynaecology and Obstetrics, quo vadis? A Department of Women’s Health—University Women’s Hospital of the future?
por: Simoes, Elisabeth, et al.
Publicado: (2014)

Routine postoperative blood tests fail to reliably predict procedure-related complications after laparoscopic cholecystectomy
por: Strohäker, Jens, et al.
Publicado: (2021)

Perioperative Antibiotics in Appendicitis—Do We Need to Adjust Therapy for the Elderly? A Matched Pair Analysis
por: Strohäker, Jens, et al.
Publicado: (2022)

Opinion paper: gynecological surgery in local anesthesia?
por: Neis, Felix, et al.
Publicado: (2022)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification
por: Wallwiener, Markus, et al.
Publicado: (2012)

The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute study
por: Bai, Huimin, et al.
Publicado: (2016)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
por: Wohlmuth, Christoph, et al.
Publicado: (2022)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
por: Chen, Jie-Ping, et al.
Publicado: (2019)

The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma
por: Menczer, Joseph, et al.
Publicado: (2015)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
por: Jin, Xiayu, et al.
Publicado: (2022)

Adenocarcinoma arising in a cystic duplication of the small bowel: case report and review of literature
por: Blank, Gregor, et al.
Publicado: (2012)

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer
por: Zhang, Wei, et al.
Publicado: (2018)

The added value of CA125, HE4, and CA72-4 as markers for ovarian endometriosis diagnosis
por: Micu, Romeo, et al.
Publicado: (2023)

A combination of transcriptome and methylation analyses reveals embryologically-relevant candidate genes in MRKH patients
por: Rall, Katharina, et al.
Publicado: (2011)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Cellular Liver Regeneration after Extended Hepatic Resection in Pigs
por: Ladurner, Ruth, et al.
Publicado: (2009)

Cancer-Selective Treatment of Cancerous and Non-Cancerous Human Cervical Cell Models by a Non-Thermally Operated Electrosurgical Argon Plasma Device
por: Feil, Lukas, et al.
Publicado: (2020)

Save our surgeons (SOS) – an explorative comparison of surgeons’ muscular and cardiovascular demands, posture, perceived workload and discomfort during robotic vs. laparoscopic surgery
por: Krämer, Bernhard, et al.
Publicado: (2022)

Appendiceal diverticulitis shortly after a performed laparoscopic sigma resection
por: Lange, Jessica, et al.
Publicado: (2015)

Prognostic relevance of acquired uniparental disomy in serous ovarian cancer
por: Tuna, Musaffe, et al.
Publicado: (2015)

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer
por: Heitz, Florian, et al.
Publicado: (2022)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Liposarcoma of the Spermatic Cord: Impact of Final Surgical Intervention—An Institutional Experience
por: Bachmann, R., et al.
Publicado: (2016)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births
por: Brucker, Sara Yvonne, et al.
Publicado: (2020)

Benchmarking the quality of breast cancer care in a nationwide voluntary system: the first five-year results (2003–2007) from Germany as a proof of concept
por: Brucker, Sara Y, et al.
Publicado: (2008)

The Prevalence and Clinical Significance of Anaerobic Bacteria in Major Liver Resection
por: Strohäker, Jens, et al.
Publicado: (2021)

Clinical Presentation and Incidence of Anaerobic Bacteria in Surgically Treated Biliary Tract Infections and Cholecystitis
por: Strohäker, Jens, et al.
Publicado: (2021)

Primary admission to a surgical service facilitates early cholecystectomy in acute cholecystitis but does not influence patient outcome
por: Strohäker, Jens, et al.
Publicado: (2023)

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
por: Stasenko, Marina, et al.
Publicado: (2021)

New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review
por: Bachmann, Cornelia
Publicado: (2023)

Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review
por: İyibozkurt, Ahmet Cem, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9iij4paq7uvpq8grdf74cu1v93